Dymon Asia Capital »

Tango Therapeutics shares owned by Dymon Asia Capital

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by Dymon Asia Capital from 13F filings

Historical chart of Dymon Asia Capital investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by Dymon Asia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by Dymon Asia Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $313k 10k 31.26

More positions owned by Dymon Asia Capital

Vaneck Etf Trust Semiconductr Etf (SMH)
Ishares Msci Sth Kor Etf Put Option (EWY)
Roundhill Etf Trust Memory Etf Put Option
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Micron Technology (MU)
Intel Corporation Put Option (INTC)
Nokia Corp Sponsored Adr (NOK)
Seagate Technology Hldngs Pl Ord Shs (STX)
Delek Us Holdings (DK)
Advanced Micro Devices Put Option (AMD)
NVIDIA Corporation Call Option (NVDA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Put Option (UNH)
Valero Energy Corporation (VLO)

View all positions for Dymon Asia Capital

Top funds holding Tango Therapeutics

Rtw Investments
BlackRock
FMR
Farallon Capital Management
Boxer Capital Management
Goldman Sachs Group
TCG Crossover Management
Trv Gp Iv
Paradigm Biocapital Advisors
Siren
Vanguard Capital Management
Adage Capital Partners GP
Jupiter Topco
State Street Corporation
Deep Track Capital

View all funds holding Tango Therapeutics